Authors
Latest:
The Future of Launch Excellence is Generative AIHow drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.
Latest:
Gaining Payer Attention Through Digital InnovationIn this case study, learn how to increase payer engagement, drive awareness, monitor competition, and leverage insights to enhance strategic plans and launch success.
Latest:
Changing the Digital Health Playing Field: A New EraThe shift to clinical-grade support offers great opportunity.
Latest:
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to StartBy demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.
Latest:
Drug Diversion in Healthcare is a National Problem, but Recent Survey Shows a Promising Path ForwardHealthcare organizations can lower their risk of drug diversion by strengthening staffing, employee training, and technology.
Latest:
This is Your Wake-Up Call–Sunshine Act Enforcement is HereMitigating potential risk for stakeholders in light of latest Sunshine Act developments.
Latest:
Virtual’s Long-View Reality: Future Priorities and PerspectivesTelemedicine is definitely here to stay, but recent study may offer clues on its sustaining power.
Latest:
Aspiring for the C-Suite? Consider Being a Chief of StaffWhy this role provides a critical ‘boot camp’ for future pharma leaders.
Latest:
Beyond Images: 2024 Trends Reshaping Healthcare with RadiopharmaceuticalsBy capitalizing on AI advancements, pushing the boundaries of personalized medicine with theranostics, and strengthening digital healthcare networks, radiopharmaceuticals are poised to transform healthcare from a reactive to a proactive discipline.
Latest:
Sustainability Sea Change: The Top 5 ESG Challenges for PharmaOutlining the most important sustainability-related hurdles facing leading biopharma companies today—and current efforts underway to meet new expectations in advancing this strategic mandate.
Latest:
Keys to Success for Social Media in Healthcare AdvertisingHow to build a loyal audience of brand evangelists.
Latest:
Teamwork for Better Healthcare Solutions: Merging Clinical and Marketing EffortsIn the ever-evolving landscape of healthcare, it's vital for organizations to take steps toward bridging the gap between their clinical and marketing teams.
Latest:
CRISPR: Maximizing this Revolutionary Genetic Tool While Minimizing IP RiskNew technology serves as reminder for the appropriate uses of CRISPR.
Latest:
Accelerate Pharmaceutical Discovery with End-to-End Scientific Informatics PlatformPerkinElmer Informatics’ Signals Solution Addresses Needs of Research and Clinical Scientists
Latest:
The Importance of Imaging and Centralized Review in Clinical TrialsImaging is an integral part of many clinical studies, particularly in the fields of oncology and ophthalmology. Learn why imaging and centralized review are essential for clinical trials, how to address challenges that arise in these studies, and the advantages of partnering with MERIT in this video.
Latest:
Building Healthcare Consumers’ Trust in Personalized Digital and Data-Led ServicesThe next few years will require life science companies to bring consumer-facing digital services to the core of their corporate competence, rather than leaving it at the periphery of their business capabilities.
Latest:
Accelerating New Medicines: Innovation and Technology at CuriaCuria is proud to partner with pharma and biotech companies to make new medicines that save lives. In order to be able to do that, Curia needs to be constantly innovating. In this podcast, you will learn from Curia’s VP of Portfolio and Sourcing, James Grabowski, about Curia’s small and large molecules most recent technologies, and capabilities.
Latest:
Beyond the Data: Is Blockchain the Answer to Improving Global Health?The COVID-19 pandemic has shifted the adoption of digital platforms in pharma and has made the industry reconsider which technologies can improve global health moving forward.
Latest:
How to Overcome Inertia and Adopt Omnichannel Marketing for PharmaOmnichannel marketing touts delivering efforts across all channels simultaneously, and looks to dethrone the incumbent multichannel marketing, but making the switch isn't exactly easy.
Latest:
Reimagining Medical Education for the Digital AgeEmbracing new digital-based tools is critical throughout the healthcare landscape to prepare for the rise of telemedicine as a permanent way of life.
Latest:
Bottom of the Funnel Conversion though EHR Marketing and its Role in an Omnichannel StrategyWebinar Date/Time: Wed, Dec 7, 2022 2:00 PM EST
Latest:
Challenges to Navigating the Pharmaceutical Regulatory LandscapeIn the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and clinical studies and managing chemistry, manufacturing, and controls (CMC) activities.
Latest:
If Content Is King, Context Is the Power Behind the ThroneNew mediums of technology must be utilized correctly to reap full benefits.
Latest:
The Real Cost of State Drug Importation Programs? Patient SafetyImporting drugs from Canada may increase the risk of US citizens being exposed to unsafe medicines.
Latest:
Integrating Payers Into Your Digital Communication PlanAn evolving system requires a focus on digital channels
Latest:
Payers Believe Lowering Drug Prices While Improving Patient Access Is Possible—but There’s a CatchValue-based price for access (VBPA) may increase access of specialty drugs for patients.
Latest:
Pharma’s Cold Calling: CGT Space at a Critical CrossroadsAs the overall industry pipeline of allogeneic T-cell therapies expands, the onus on manufacturers and their partners to adeptly manage the complex cryogenic logistics process intensifies.
Latest:
Opening Digital Doors: Remote Selling During COVID-19Adoption of digital by biopharma reps has added an element of flexibility to their engagement strategies, resulting in better communications with HCPs.
